X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood
Abstract
Objective Turner Syndrome is associated with several phenotypic conditions associated with a higher risk of subsequent comorbidity. We aimed to evaluate the prevalence of congenital malformations and the occurrence of age-related comorbid conditions and to determine whether the frequencies of congenital and acquired conditions depend on X chromosome gene dosage, as a function of karyotype subgroup. Design and methods This national retrospective observational cohort study includes 1501 patients. We evaluated the prevalence of congenital malformations and the cumulative incidence of subsequent specific comorbidities at five-year intervals, from the ages of 10 to 30 years, with stratification by karyotype subgroup: 45,X (n = 549), 45,X/46,isoXq (n = 280), 46,X,r(X)/46,XX (n = 106), 45,X/46,XX (n = 221), presence of Y (n = 87). Results Median age was 9.4 (3.7-13.7) years at first evaluation and 16.8 (11.2-21.4) years at last evaluation. Congenital heart (18.9%) malformations were more frequent in 45,X patients, and congenital renal (17.2%) malformations were more frequent in 45,X, 45,X/46,isoXq and 46,X,r(X)/46,XX patients than in those with 45,X/46,XX mosaicism or a Y chromosome (P < 0.0001). The cumulative incidence of subsequent acquired conditions, such as thyroid disease, hearing loss, overweight/obesity, dyslipidemia and, to a lesser extent, celiac disease, glucose intolerance/type 2 diabetes, hypertension and liver dysfunction increased with age, but less markedly for patients with mosaicism than for those with other karyotypes. Patients with a ring chromosome were more prone to metabolic disorders. Conclusion These data suggest that X gene chromosome dosage, particularly for Xp genes, contributes to the risk of developing comorbidities.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rates of prematurity (birth <37 weeks' gestation) in TS are similar or only slightly higher than the general population (10%-19%), with extreme prematurity uncommon.
“Rates of prematurity (birth <37 weeks’ gestation) are similar or only slightly higher than the general population (10%-19%), with extreme prematurity uncommon.401,630,631”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [630]
Approximately one-third of infants with TS are born small for gestational age (SGA), though the degree of SGA is typically mild, but can be up to 600-1000 g lighter.
“Approximately one-third of infants with TS are born small for gestational age (SGA), though the degree of SGA is typically mild,630,631 but can be up to 600-1000 g lighter.59”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [630]
Karyotypes 45,X, 45,X/46,iso(X), and ring X appear to be at the highest risk for ear and hearing diagnoses, however the incidence rate for ear and hearing diagnoses is 35-fold higher in all TS karyotypes combined compared to the general population.
“Karyotypes 45,X, 45,X/46,iso(X), and ring X appear to be at the highest risk, however the incidence rate for ear and hearing diagnoses is 35-fold higher in all TS karyotypes combined compared to the general population.630,647”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [630]
Overweight/obesity increases from childhood to adulthood in TS, with a cumulative incidence of 8%-60% from age 10 to 30 years.
“Overweight/obesity increases from childhood to adulthood, with a cumulative incidence of 8%-60% from age 10 to 30 years.630”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [630]
Some studies have found an association of metabolic abnormalities with monosomy X, ring X, isochromosome Xq, and Xp deletion, however findings are inconsistent and require more data before clinical interpretation.
“Some studies have found an association of metabolic abnormalities with monosomy X, ring X, isochromosome Xq, and Xp deletion, however findings are inconsistent and require more data before clinical interpretation.450,630,697,703”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [630]
Genes on Xp related to beta-cell function and insulin signal transduction affect overall glucose metabolism and likely contribute to the risk of diabetes in TS, as illustrated by studies showing individuals with a 45,X karyotype or deletions of Xp to have a much higher incidence of diabetes compared to individuals with deletions isolated to Xq (17%-23% vs 9%).
“Genes on Xp related to beta-cell function and insulin signal transduction affect overall glucose metabolism and likely contribute to the risk of diabetes in TS, as illustrated by studies showing individuals with a 45,X karyotype or deletions of Xp to have a much higher incidence of diabetes compared to individuals with deletions isolated to Xq (17%-23% vs 9%).630,703”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [630]
The prevalence of coeliac disease increases with age and is highest in 45,X, 45,X/iso q or ring chromosome karyotypes where up to 7.5% have positive coeliac antibodies.
“The prevalence of coeliac disease increases with age725,726 and is highest in 45,X, 45,X/iso q or ring chromosome karyotypes where up to 7.5% have positive coeliac antibodies.26,630”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [630]
Cites
Establishing a standard definition for child overweight and obesity worldwide: international survey
Cole, T. J. (2000) · BMJ · doi:10.1136/bmj.320.7244.1240 · Cited by 16,500 · see citing works
Flynn, J. T., Kaelber, D. C., Baker-Smith, C. M., Blowey, D., Carroll, A. E., Daniels, S. R., de Ferranti, S. D., Dionne, J. M., Falkner, B., Flinn, S. K., et al. (2017) · Pediatrics · doi:10.1542/peds.2017-1904 · Cited by 3,651 · see citing works
Sybert, V. P., & McCauley, E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030360 · Cited by 918 · see citing works
Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome
Stochholm, K., Juul, S., Juel, K., Naeraa, R. W., & Højbjerg Gravholt, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0558 · Cited by 652 · see citing works
Gravholt, C. H., Juul, S., Naeraa, R. W., & Hansen, J. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00237-0 · Cited by 548 · see citing works
Cardiovascular Malformations and Complications in Turner Syndrome
Sybert, V. P. (1998) · PEDIATRICS · doi:10.1542/peds.101.1.e11 · Cited by 326 · see citing works
Epidemiological, endocrine and metabolic features in Turner syndrome
Gravholt, C. H. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510657 · Cited by 248 · see citing works
Phenotypes Associated with SHOX Deficiency
ROSS, J. L., Scott, C. I., Marttila, P., Kowal, K., Nass, A., Papenhausen, P. R., Abboudi, J., Osterman, L. A., Kushner, H., Carter, P., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8125 · Cited by 221 · see citing works
Prevalence and Clinical Picture of Celiac Disease in Turner Syndrome
Bonamico, M., Pasquino, A. M., Mariani, P., Danesi, H. M., Culasso, F., Mazzanti, L., Petri, A., & Bona, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020855 · Cited by 184 · see citing works
Autoimmune diseases in women with Turner's Syndrome
Jørgensen, K. T., Rostgaard, K., Bache, I., Biggar, R. J., Nielsen, N. M., Tommerup, N., & Frisch, M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27270 · Cited by 176 · see citing works
Autoimmune thyroid syndrome in women with Turner's syndrome—the association with karyotype
Elsheikh, M., Wass, J. A. H., & Conway, G. S. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01296.x · Cited by 171 · see citing works
Hypothyroidism is common in Turner syndrome: results of a five-year follow-up
El-Mansoury, M., Bryman, I., Berntorp, K., Hanson, C., Wilhelmsen, L., & Landin-Wilhelmsen, K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1262 · Cited by 166 · see citing works
The Turner syndrome life course project: karyotype-phenotype analyses across the lifespan
Cameron‐ Pimblett, A., La Rosa, C., King, T. F. J., Davies, M. C., & Conway, G. S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13394 · Cited by 161 · see citing works
Turner Syndrome: Updating the Paradigm of Clinical Care
Pinsker, J. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1245 · Cited by 123 · see citing works
Renal malformations in patients with Turner syndrome: imaging in 141 patients
Lippe, B., Geffner, M. E., Dietrich, R. B., Boechat, M. I., & Kangarloo, H. (1988) · PEDIATRICS · doi:10.1542/peds.82.6.852 · Cited by 122 · see citing works
Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome
El‐Mansoury, M., Barrenäs, M., Bryman, I., Hanson, C., Larsson, C., Wilhelmsen, L., & Landin‐Wilhelmsen, K. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02807.x · Cited by 122 · see citing works
Freriks, K., Timmermans, J., Beerendonk, C. C. M., Verhaak, C. M., Netea-Maier, R. T., Otten, B. J., Braat, D. D. M., Smeets, D. F. C. M., Kunst, D. H. P. M., Hermus, A. R. M. M., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0346 · Cited by 120 · see citing works
Turner syndrome and haploinsufficiency
Zinn, A. R., & ROSS, J. L. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80089-0 · Cited by 119 · see citing works
X-chromosome gene dosage and the risk of diabetes in Turner syndrome
Bakalov, V. K., Cheng, C., Zhou, J., & Bondy, C. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0384 · Cited by 118 · see citing works
Turner syndrome and clinical treatment
Hjerrild, B., Mortensen, K. H., & Gravholt, C. H. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn015 · Cited by 116 · see citing works
Livadas, S., Xekouki, P., Fouka, F., Kanaka‐Gantenbein, C., Kaloumenou, I., Mavrou, A., Constantinidou, N., & Dacou‐Voutetakis, C. (2005) · Thyroid · doi:10.1089/thy.2005.15.1061 · Cited by 114 · see citing works
Bondy, C. A., Bakalov, V. K., Cheng, C. M., Olivieri, L., Rosing, D. R., & Arai, A. E. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101720 · Cited by 90 · see citing works
Determinants of medical care for young women with Turner syndrome
Devernay, M., Ecosse, E., Coste, J., & Carel, J.-C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0495 · Cited by 79 · see citing works
Epigenetics in Turner syndrome
Álvarez-Nava, F., & Lanes, R. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0477-0 · Cited by 79 · see citing works
Frequency of renal malformations in Turner syndrome: analysis of 82 Turkish children
Bilge, I., Kayserili, H., Emre, S., Nayir, A., Sirin, A., Tukel, T., Bas, F., Kilic, G., Basaran, S., Gunoz, H., et al. (2000) · Pediatric Nephrology · doi:10.1007/s004670000315 · Cited by 77 · see citing works
Celiac Disease and Turner Syndrome
Bonamico, M., Bottaro, G., Pasquino, A. M., Caruso‐Nicoletti, M., Mariani, P., Gemme, G., Paradiso, E., Ragusa, M. C., & Spina, M. (1998) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199805000-00002 · Cited by 67 · see citing works
The influence of karyotype on the auricle, otitis media and hearing in Turner syndrome
Barrenäs, M., Nylén, O., & Hanson, C. (1999) · Hearing Research · doi:10.1016/s0378-5955(99)00162-8 · Cited by 64 · see citing works
Lebenthal, Y., Levy, S., Sofrin-Drucker, E., Nagelberg, N., Weintrob, N., Shalitin, S., de Vries, L., Tenenbaum, A., Phillip, M., & Lazar, L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00027 · Cited by 60 · see citing works
Alwan, I. A. A., Khadora, M. M., & Amir, I. (2014) · International Journal of Health Sciences · doi:10.12816/0006086 · Cited by 54 · see citing works
Gawlik, A., Gawlik, T., Januszek-Trzciąkowska, A., Patel, H., & Małecka‐Tendera, E. (2011) · Hormone Research in Paediatrics · doi:10.1159/000331050 · Cited by 53 · see citing works
Differences in carbohydrate tolerance in Turner syndrome depending on age and karyotype
Cicognani, A., Mazzanti, L., Tassinari, D., Pellacani, A., Forabosco, A., Landi, L., Pifferi, C., & CACCIARI, E. (1988) · European Journal of Pediatrics · doi:10.1007/bf00441818 · Cited by 51 · see citing works
Hearing loss in Turner syndrome: Results of a multicentric study
Bergamaschi, R. C., Bergonzoni, C., Mazzanti, L., Scarano, E., Mencarelli, F., Messina, F., Rosano, M., Iughetti, L., & Cicognani, A. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03349257 · Cited by 50 · see citing works
Calcaterra, V., Brambilla, P., Maffè, G. C., Klersy, C., Albertini, R., Introzzi, F., Bozzola, E., Bozzola, M., & Larizza, D. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0075 · Cited by 44 · see citing works
Prevalence of renal malformation in Turner syndrome
Flynn, M. T., Ekstrom, L., Arce, M. D., Costigan, C., & Hoey, H. (1996) · Pediatric Nephrology · doi:10.1007/s004670050148 · Cited by 41 · see citing works
Calanchini, M., Moolla, A., Tomlinson, J. W., Cobbold, J. F., Grossman, A., Fabbri, A., & Turner, H. E. (2018) · Clinical Endocrinology · doi:10.1111/cen.13811 · Cited by 41 · see citing works
Frost, A. R., Band, M. M., & Conway, G. S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0846 · Cited by 38 · see citing works
Bettendorf, M., Doerr, H. G., Hauffa, B. P., Lindberg, A., Mehls, O., Partsch, C., H.-P. Schwarz, Stahnke, N., & Ranke, M. B. (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.2.149 · Cited by 36 · see citing works
Fiot, E., Zénaty, D., Boizeau, P., Haigneré, J., Santos, S. D., Léger, J., & _, _. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-1000 · Cited by 32 · see citing works
New approach to phenotypic variability and karyotype-phenotype correlation in Turner syndrome
Neto, J. M., de Carvalho, A. B., Marques‐de‐Faria, A. P., Guerra‐Júnior, G., & Maciel‐Guerra, A. T. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0346 · Cited by 32 · see citing works
Lim, D., Gault, E. J., Kubba, H., Morrissey, M. S. C., Wynne, D., & Donaldson, M. (2014) · Acta Paediatrica · doi:10.1111/apa.12622 · Cited by 29 · see citing works
Otologic disorders in Turner syndrome
Bois, E., Nassar, M., Zénaty, D., Léger, J., Abbeele, T. V. D., & Teissier, N. (2017) · European Annals of Otorhinolaryngology Head and Neck Diseases · doi:10.1016/j.anorl.2017.08.006 · Cited by 27 · see citing works
Yetman, A. T., Starr, L., Sanmann, J., Wilde, M., Murray, M., & Cramer, J. W. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.03.357 · Cited by 24 · see citing works
Hanew, K., Tanaka, T., Horikawa, R., Hasegawa, T., & Yokoya, S. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0401 · Cited by 23 · see citing works
Hamza, R. T., Raof, N. A., & Abdallah, K. M. A. M. (2013) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2012-0265 · Cited by 19 · see citing works
Audiological Abnormalities in Patients With Turner Syndrome
Oliveira, C. S., Ribeiro, F. M., Lago, R., & Alves, C. (2013) · American Journal of Audiology · doi:10.1044/1059-0889(2013/11-0027 · Cited by 18 · see citing works
Verver, E. J. J., Freriks, K., Sas, T., Huygen, P. L. M., Pennings, R. J. E., Smeets, D., Hermus, A. R., Menke, L. A., Wit, J. M., Otten, B. J., et al. (2014) · Otology & Neurotology · doi:10.1097/mao.0000000000000406 · Cited by 18 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224 · see citing works
A Review of Recent Developments in Turner Syndrome Research
Huang, A. C., Olson, S. B., & Maslen, C. L. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8110138 · Cited by 75 · see citing works
“The 45,X, 45,X/46,X,i(Xq), and 46,X,r(X)/46,XX karyotypes have increased risk of renal defects [24].”
BackgroundInfluentialFiot, E., Alauze, B., Donadille, B., Samara‐Boustani, D., Houang, M., FILIPPO, G. D., Bachelot, A., Delcour, C., Beyler, C., Bois, E., et al. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02423-5 · Cited by 49 · see citing works
The genetics of isolated congenital heart disease
Nees, S. N., & Chung, W. K. (2019) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31763 · Cited by 45 · see citing works
“…variants and additional stud- ies are necessary to fully assess mosaicism as a contributor to CHD. Cytogenetic studies have demonstrated that individuals with mosaic trisomies can have CHD without associated syndromic features (Fiot et al., 2019; Yokoyama, Narahara, Kamada, Tsuji, & Seino, 1992).”
BackgroundAdded value of buccal cell FISH analysis in the diagnosis and management of Turner syndrome
Graff, A., Donadille, B., Morel, H., Villy, M. C., Bourcigaux, N., Vatier, C., Borgel, A., Khodawardi, A., Siffroi, J. P., & Christin-Maitre, S. (2020) · Human Reproduction · doi:10.1093/humrep/deaa197 · Cited by 30 · see citing works
Donadille, B., & Christin‐Maître, S. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.12.004 · Cited by 26 · see citing works
Novel insights in Turner syndrome
Aly, J. M., & Kruszka, P. S. (2022) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001135 · Cited by 21 · see citing works
“Congenital malformations of the renal/urinary system are present in approximately 30–40% of patients with Turner syndrome [91,92] and include horseshoe kidney, hydronephrosis, duplex collecting system, and single unilateral kidney.”
BackgroundGambineri, A., Scarano, E., Rucci, P., Perri, A., Tamburrino, F., Altieri, P., Corzani, F., Cecchetti, C., Dionese, P., Belardinelli, E., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01853-z · Cited by 18 · see citing works
Cardiovascular manifestations of Turner syndrome: phenotypic differences between karyotype subtypes
Birjiniuk, A., Weisman, A. G., Laternser, C., Camarda, J., Brickman, W. J., Habiby, R., & Patel, S. R. (2024) · Pediatric Cardiology · doi:10.1007/s00246-023-03159-0 · Cited by 18 · see citing works
Donadille, B., Tuffet, S., Cholet, C., Nedelcu, M., Bourcigaux, N., Iserin, L., Monnier‐Cholley, L., Rousseau, A., & Christin‐Maître, S. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0284 · Cited by 19 · see citing works
The epidemiology of disorders of sex development
Berglund, A., Chang, S., Lind‐Holst, M., Stochholm, K., & Gravholt, C. H. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102002 · Cited by 17 · see citing works
Jamalinia, M., Saeian, S., Nikkhoo, N., Nazerian, A., & Lankarani, K. B. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.131 · Cited by 17 · see citing works
Chromosomal Abnormalities of Interest in Turner Syndrome: An Update
Ibarra‐Ramírez, M., Campos-Acevedo, L. D., & Villarreal, L. (2023) · Journal of Pediatric Genetics · doi:10.1055/s-0043-1770982 · Cited by 12 · see citing works
Characterization of Turner Syndrome-associated Diabetes Mellitus
Cameron‐Pimblett, A., Rosa, C. L., Davies, M. C., Suntharalingham, J. P., Ishida, M., Achermann, J. C., & Conway, G. S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae357 · Cited by 12 · see citing works
“Further, the isochromosome and ring chromosome subgroups have been reported to be associated with DM risk when compared to the 45,X subgroup, believed to be the result of abnormal gene dosing (3, 12, 13).”
Renal morphology and function from childhood to adulthood in Turner syndrome
Ogawa, T., Takizawa, F., Mukoyama, Y., Ogawa, A., & Ito, J. (2021) · Clinical and Experimental Nephrology · doi:10.1007/s10157-021-02031-w · Cited by 10 · see citing works
Wang, G., Liu, X., Wang, M., Wang, J., Zhang, Z., Allegaert, K., Mei, D., Zhang, Y., Luo, S., Fang, Y., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1324160 · Cited by 9 · see citing works
Prevalence of otological disease in Turner syndrome: a systematic review
Geerardyn, A., Willaert, A., Decallonne, B., Desloovere, C., & Verhaert, N. (2021) · Otology & Neurotology · doi:10.1097/mao.0000000000003118 · Cited by 9 · see citing works
The prevalence of hypertension in paediatric Turner syndrome: a systematic review and meta-analysis
McCarrison, S., Carr, A., Wong, S. C., & Mason, A. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00777-8 · Cited by 9 · see citing works
“Studies which have assessed the natural history of hypertension in a TS population have shown an increased prevalence of hypertension with age [41, 52].”
BackgroundClemente, E. G., Penukonda, S. K., Doan, T., Sullivan, B. A., & Kanungo, S. (2022) · Endocrines · doi:10.3390/endocrines3020022 · Cited by 9 · see citing works
Hyperglycemia in Turner syndrome: Impact, mechanisms, and areas for future research
Mitsch, C., Alexandrou, E., Norris, A. W., & Pinnaro, C. T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1116889 · Cited by 11 · see citing works
Zeng, J., Luo, F., Lin, Z., Chen, Y., Wang, X., & Song, Y. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00819-1 · Cited by 9 · see citing works
“A recent study has shown that patients with TS with karyotypes 45, X/46, isoXq and 45 X have a higher prevalence of complications, including ATD, than patients with mosaic 45, X/46, XX or Y chromosomes [12].”
BackgroundBourcigaux, N., Dubost, E., Buzzi, J.-C., Donadille, B., Corpechot, C., Poujol-Robert, A., & Christin-Maitre, S. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad108 · Cited by 8 · see citing works
Self-citationCRELD1 variants are associated with bicuspid aortic valve in Turner syndrome
Pinnaro, C. T., Beck, C. B., Major, H. J., & Darbro, B. W. (2023) · Human Genetics · doi:10.1007/s00439-023-02538-0 · Cited by 8 · see citing works
“45,X karyotype has the strongest association with CHD in TS (Fiot et al. 2019), however, this is neither necessary nor sufficient to cause CHD in TS.”
BackgroundApproach to the Patient With Turner Syndrome
Turner, H. E., Johannsen, E. B., Smyth, A., Orchard, E., & Gravholt, C. H. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf517 · Cited by 11 · see citing works
Zaegel, N., Brahimaj, R., Battaglia-Hsu, S.-F., Lamiral, Z., & Feigerlová, E. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae099 · Cited by 6 · see citing works
“In line with other reports [4, 8, 13], the results of the present study indicate that the prevalence of liver dysfunction in patients with TS increases with age.”
ResultHigher CNV Frequencies in Chromosome 14 of Girls With Turner Syndrome Phenotype
Purwar, N., Tiwari, P., Mathur, N., Sharma, H., Sahlot, R., Garg, U., Sharma, B., Saxena, A., & Mathur, S. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab572 · Cited by 7 · see citing works
Bedei, I. A., Bruder, J., Lund, I. C. B., Thomsen, S. H., Vogel, I., Maciel‐Guerra, A. T., Álvarez‐Nava, F., Crenshaw, M., Axt-Fliedner, R., Gravholt, C. H., et al. (2025) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.32136 · Cited by 6 · see citing works
“…associations have been identified, both prenatally and postnatally, and these primarily reflect the magnitude of the loss of X chromosome material (Cameron-Pimblett et al. 2017; Gravholt et al. 2023; Noordman et al. 2019; Fiot et al. 2019; Snyder et al. 2021; El-Mansoury et al. 2007).”
Incidence and risk factors of hearing loss in patients with Turner Syndrome
Lin, H., Wang, X., Qin, S., Luo, F., Cen, Y., Lash, G. E., & Li, L. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1076812 · Cited by 5 · see citing works
“It has also been shown that patients with mosaic karyotypes are more likely to develop dyslipidemia than patients with other karyotypes, while patients with circular chromosomes are more likely to develop metabolic disorders (22).”
BackgroundElevated levels of neutrophils with a pro-inflammatory profile in Turner syndrome across karyotypes
Just, J., Ridder, L. O. R., Johannsen, E. B., Jensen, J. M. B., Petersen, M. S., Christensen, H. V., Kjærgaard, K., Redder, J. D., Chang, S., Stochholm, K., et al. (2025) · npj Genomic Medicine · doi:10.1038/s41525-025-00467-7 · Cited by 5 · see citing works
“This correlation was particularly present in individuals with high BMI, increased waist-to-hipratio,andelevatedtriglyceridelevels,indicating apotentiallink between this gene network and cardiovascular and metabolic risk factors in TS 7,12,44 .”
Management of a Girl With Delayed Puberty and Elevated Gonadotropins
McGlacken-Byrne, S. M., Achermann, J. C., & Conway, G. S. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac108 · Cited by 6 · see citing works
Meta‐Analysis: Liver Disease Burden and Associated Factors in Turner Syndrome
Jamalinia, M., Zare, F., Mantovani, A., Targher, G., & Lonardo, A. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70457 · Cited by 5 · see citing works
“Full texts of 59 potentially eligible articles were assessed, and 40 studies [3, 4, 8, 10, 22– 57 ] ultimately met the”
X-chromosome gene dosage shapes MASLD beyond sex hormones
Jamalinia, M., Targher, G., & Lonardo, A. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.05.001 · Cited by 3 · see citing works
Álvarez‐Nava, F., Crenshaw, M., Bedei, I. A., Soto, M., Maciel‐Guerra, A. T., & Skakkebaek, A. H. (2025) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.32146 · Cited by 2 · see citing works
Johannsen, E. B., Just, J., Chang, S., Skakkebaek, A. H., & Gravholt, C. H. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01963-4 · Cited by 1 · see citing works
Shen, Y., Song, C., Du, Y., Wang, L., Li, X., Shi, Y., Ye, D., Dong, S., & Liu, H. (2025) · Medicine · doi:10.1097/md.0000000000044519 · Cited by 1 · see citing works
Jamalinia, M., Lonardo, A., & Weiskirchen, R. (2026) · Chronic Diseases and Translational Medicine · doi:10.1002/cdt3.70038 · Cited by 1 · see citing works
Association between Cardiac Malformations and Karyotype in Turner Syndrome - a Single Centre Study
Lazea, C., Bucerzan, S., Alkhzouz, C., Creț, V., Crișan, M., Miclea, D., & Grigorescu‐Sido, P. (2021) · Romanian Journal of Cardiology · doi:10.47803/rjc.2020.31.4.847 · Cited by 1 · see citing works
The Influence of X Chromosome Parent-of-Origin on Glycemia in Individuals with Turner Syndrome
Pinnaro, C. T., Zimmerman, B. I., Ryckman, K. K., Darbro, B. W., & Norris, A. W. (2024) · Hormone Research in Paediatrics · doi:10.1159/000542677 · Cited by 1 · see citing works
Systemic immune-inflammatory indices are associated with liver dysfunction in Turner syndromePreprint
Feigerlová, E., Zaegel, N., Brahimaj, R., Battaglia-Hsu, S.-F., Lamiral, Z., & Feigerlová, E. (2022) · Research Square · doi:10.21203/rs.3.rs-2263839/v1
Turner Syndrome: results of the first Tunisian study group on Turner Syndrome (TuSGOT)
Essaddam, L., Zitouni, O., Kraoua, L., Trabelsi, M., Sassi, H., Kmiha, S., Charfi, F., Guiche, D. E., Kebaïli, R., Jaballah, N., et al. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0360
Turner syndrome with isochromosome Xq as a cause of granulomatous hepatitis: a case report
Ali, A. F., & Haffar, L. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002042
“A study conducted by Calanchini et al. [12] on a cohort of 125 women with TS revealed a correlation between raised liver function tests and a speci fi c karyotype iso[X]q. Interestingly, another study conducted on the same subject matter yielded similar fi ndings [13] .”
ResultAdult care of Turner syndrome women
Gravholt, C. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00164-3
Huang, Y., Luo, S., Qi, Y., Qin, S., Yue, C., Lu, Q., Lash, G. E., & Li, L. (2026) · Research Square · doi:10.21203/rs.3.rs-9246643/v1
Huang, Y., Luo, S., Qi, Y., Qin, S., Yue, C., Lu, Q., Lash, G. E., & Li, L. (2026) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-026-04457-5
Influence of X-Chromosome Inactivation in Pathogenesis of Turner Syndrome
Grigore, A. M., Caba, L., Iacob, V. T., Antoci, L.-M., Pânzaru, M.-C., Butnariu, L. I., & Gorduza, E. V. (2026) · Epigenomes · doi:10.3390/epigenomes10030043
“Ring X chromosomes—46,X,r(X)—represent a rare heterogeneous class of TS rearrangements [149,150].”
Bashir, I. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27660-6.00010-9
de Paillette, E., Karila, D., Rousseau, A., Dubost, E., Meykiechel, T., Lamothe, S., Vatier, C., Jaillard, S., Nedelcu, M., Bourcigaux, N., et al. (2026) · Sexual Medicine · doi:10.1093/sexmed/qfag074
“…than the percentages obser ved in different studies including patients with TS. 1 , 17 A s patients with mosaicism have a milder phenotype than patients with 45,X homogenous kar yotype, 43 the percentage of women with mosaicism could explain higher FSFI-6 scores in the TS group than expected.”
New genomic understanding and challenges in clinical care of Turner syndrome
Gravholt, C. H., Balle, C. M., Johannsen, E. B., Valsted, L. B., Hartogsohn, E. A. R., Bedei, I. A., Just, J., Backeljauw, P. F., & Stochholm, K. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00192-0
- Authors
- Fiot, E., Zénaty, D., Boizeau, P., Haignere, J., Dos Santos, S., Léger, J., _, _., _, _., Carel, J. C., Cabrol, S., Chanson, P., Christin-Maitre, S., Courtillot, C., Donadille, B., Dulon, J., Houang, M., Nedelcu, M., Netchine, I., Polak, M., Salenave, S., Samara-Boustani, D., Simon, D., Touraine, P., Viaud, M., Bony, H., Braun, K., Desailloud, R., Bertrand, A. M., Mignot, B., Schillo, F., Barat, P., Kerlan, V, Metz, C., Sonnet, E., Reznik, Y., Ribault, V, Carla, H., Tauveron, I., Bensignor, C., Huet, F., Verges, B., Chabre, O., Dupuis, C., Spiteri, A., Cartigny, M., Stuckens, C., Weill, J., Lienhardt, A., Naud-Saudreau, C., Borson-Chazot, F., Brac de la Perriere, A., Pugeat, M., Brue, T., Reynaud, R., Simonin, G., Paris, F., Sultan, C., Leheup, B., Weryha, G., Baron, S., Charbonnel, B., Dubourdieu, S., Baechler, E., Fenichel, P., Wagner, K., Compain, F., Crosnier, H., Personnier, C., Delemer, B., Hecart, A. C., Souchon, P. F., De Kerdanet, M., Galland, F., Nivot-Adamiak, S., Castanet, M., Lecointre, C., Richard, O., Jeandidier, N., Soskin, S., Lecomte, P., Pepin-Donat, M., & Pierre, P.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Inserm (FR)
- 1Assistance Publique-Hôpitaux de Paris, Robert Debré University Hospital, Pediatric Endocrinology Diabetology Department, Reference Centre for Endocrine Growth and Development Diseases, Paris, France
- Centre Hospitalier Universitaire de Montpellier (FR)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Centre Hospitalier Universitaire de Besançon (FR)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Centre Hospitalier Régional Universitaire de Brest (FR)
- Centre Hospitalier Universitaire de Caen Normandie (FR)
- Centre Hospitalier Universitaire de Grenoble (FR)
- Laboratoire de recherche en cardiovasculaire, métabolisme, diabétologie et nutrition (FR)
- Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (FR)
- Institut de Génétique Humaine (FR)
- Nutrition-Génétique et Exposition aux Risques Environnementaux (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- European Organization for Nuclear Research (CH)
- Centre d’Immunologie de Marseille-Luminy (FR)
- Différenciation et Communication Neuronale et Neuroendocrine (FR)
- Laboratoire d'Ingénierie Circulation Transports (FR)
- Corresponding author
- Léger, Juliane
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-06
- Volume
- 180
- Issue
- 6
- Pages
- 397-406
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2938655862
- Cited by
- 48
- References
- 46
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 6 · 2020: 3 · 2019: 1
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- Turner syndrome, congenital malformations, age-related comorbidities, 45,X/46,XX mosaicism, ring chromosomes, congenital heart disease, renal anomalies, thyroid dysfunction, hearing loss, obesity, dyslipidemia, type 2 diabetes, hypertension, liver dysfunction, celiac disease, impaired glucose tolerance
- MeSH terms
- Congenital Abnormalities, Adolescent, Adult, Age Factors, Child, Female, Heart Defects, Congenital, Humans, Kidney, Kidney Diseases, Mosaicism, Retrospective Studies, Risk Factors, Turner Syndrome, Cohort Studies, Comorbidity, Gene Dosage, Chromosomes, Human, X, Young Adult, Karyotype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review